LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation

Abstract Background Glioblastoma multiforme (GBM) represents the most prevalent form of primary malignant tumor within the central nervous system. The emergence of resistance to radiotherapy and chemotherapy represents a significant impediment to advancements in glioma treatment. Methods We establis...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wenrui Zang, Yangwu Liu, Jiajun Zheng, Yifeng Huang, Lei Chen, Chiyang Li, Jiakun Zhao, Qiang Zhou, Yangheng Xu, Zhenyuan Wang, Yongfu Cao, Wanling Zhang, Junjie Li, Yuntao Lu
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-12-01
Col·lecció:	Cancer Cell International
Matèries:	GBM TMZ Radiotherapy LAT4 Amino acid metabolism mTOR pathway
Accés en línia:	https://doi.org/10.1186/s12935-024-03590-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!